Skip to content

DEARGEN UPDATES

Technical & News Articles about Deargen

Press Enter / Return to begin your search.

All articles filed in language:english

NEWS2021년 12월 23일2021년 12월 23일

Deargen Announces Patent Application for a TNBC Target Novel Drug Candidate Using AI

Deargen applied patent for a novel target compound candidate.

Read More
NEWS2021년 4월 30일2021년 8월 11일

Deargen-Samsung Medical Center signed a joint research agreement using ‘AI for The Development of Alzheimer Treatment’

Deargen collaboration with Samsung Seoul Hospital, to discover new Alzheimer’s treatments using AI technology.

Read More
NEWS2021년 4월 9일2021년 8월 10일

Deargen Announces New Model of Optimizing Drug Candidate Molecules With Enhanced Performance by Nearly Double Compared to Existing Models

At ACM CHIL 2021, Deargen presented study results on a model of simultaneously optimizing multiple properties of molecules.

Read More
NEWS2021년 3월 25일2021년 8월 10일

Deargen, Nominated as TOP10 for bioanalytical service company

Deargen: Laveraging AI to Accelerate New Drug Development.

Read More
NEWS2021년 2월 16일2021년 8월 10일

Deargen-Uppthera, co-development of Proteolytic drugs

Deargen and Uptera selected two target proteins, including anti-cancer drugs, and signed a joint research contract.

Read More
NEWS2021년 2월 5일2021년 8월 10일

AI-based Drug Discovery, What would be the limitation?

AI-based Drug Discovery, What would be the limitation?

Read More
NEWS2021년 1월 6일2021년 8월 11일

Handok- Signed a new drug development contract using artificial intelligence of Deargen

HANDOK and Deargen will conduct joint researches on “oncology” and other diseases using DearDTI.

Read More
NEWS2020년 11월 17일2021년 8월 10일

Daewoong Pharmaceutical subsidiary IN Therapeutics, now developing Hearing Loss Treatment

Deargen collaboration with IN Therapeutics collaboration to develop a treatment for hearing loss.

Read More
NEWS2020년 11월 9일2021년 8월 10일

[Press Release] Deargen- SK Chemicals- Joint research on new drug development using AI of Deargen

SKChemical and Deargen will conduct joint researches on “drug repositioning” and “de novo drug design.” 

Read More
NEWS2020년 11월 3일2021년 8월 10일

Deargen to attract 3 billion won for pre series A, recruited CBO Youngchul Bae

Deargen to attract 3 billion won for pre series A, recruited CBO Youngchul Bae

Read More

Page navigation

  • 1
  • 2
  • 3
  • 4
  • Next
DEARGEN UPDATES
WordPress가 지원합니다 테마: Ippo.
 

댓글 로드중...